Variable | Number/Mean/Percentage | Hazard Ratio | 95% Confidence Interval | p-value |
---|---|---|---|---|
LV GLS Quartile 2 (−14.15 to −10.55) | N = 51 | 3.16 | 1.26–7.90 | 0.014 |
LV GLS Quartile 3 (−10.54 to −6.41) | N = 52 | 5.19 | 1.70–15.82 | 0.004 |
LV GLS Quartile 4 (> − 6.41) | N = 51 | 5.30 | 1.43–19.60 | 0.012 |
LV GLS as a continuous variablea | −10.6 ± 4.7% | 1.23 | 1.09–1.40 | 0.001 |
Age | 63.8 ± 15 | 1.02 | 1.002–1.03 | 0.027 |
Left ventricular ejection fraction | 40 ± 17% | 0.98 | 0.95–1.02 | 0.288 |
History of ischemic heart disease | 39% | 1.13 | 0.71–1.78 | 0.608 |
NYHA III | 29% | 1.79 | 0.98–3.29 | 0.060 |
Use of ACEI/ARBs | 70% | 0.96 | 0.565–1.65 | 0.894 |
Systolic blood pressure | 149 ± 38 | 0.999 | 0.99–1.01 | 0.689 |
Sodium level | 138 ± 3 | 0.94 | 0.88–1.00 | 0.53 |